Skip to main content

Table 2 Epidemiologic and histologic characterizations between low risk EC women with and without recurrences

From: Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer

  EC FFPE primary tumor no recurrence, N = 14 EC FFPE primary tumor recurrences, N = 7 p-value
Age, median (IQR) 60 (45–82) 66 (57–76) 0.45
Diabetes n (%) 1 (7%) 1 (14%) 1
Dyslipidemia n (%) 2 (14%) 1 (14%) 1
Parity, median (IQR) 2 (0–5) 2 (1–4) 0.93
BMI, median (IQR) 28 (18–39) 26 (23–36) 0.60
Histologic grade, n (%)    1
 Grade 1 12 (85%) 6 (85%) 0.70
 Grade 2 2 (15%) 1 (15%)
 Tumor size (mm), median (IQR) 16 (5–50) 35 (9–45)
Time between surgery and sample analysis (months), median (IQR) 165 (94–204) 137 (59–202) 0.52
Vaginal brachytherapy after surgery 10 (71%) 2 (28%) 0.16
  1. EC endometrial cancer, FFPE formalin–fixed paraffin-embedded, IQR interquartile range, BMI body mass index